Skip To Main Content
Robert Laszewski on Muck Rack

Robert Laszewski

  • Blogger, Health Care Policy and Marketplace Review
Alexandria, Washington, D.C.
As seen in: Forbes, USA Today, CNBC, National Review, RealClear Politics, MedPage Today, Cato Institute, KevinMD.com, Healthcare Finance News, The Health Care Blog (THCB) and
I spent 20 years in the health insurance marketplace and another 25 years inside the Beltway. I ran two health insurance businesses before coming to Washington.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Why you need a GLP-1 exit plan

|
By Holli Bradish-Lane, Dawn Baker, Robert Laszewski, Andy Schoonover
| KevinMD.com
I’ve seen clients start GLP-1 medications full of hope, and stop them feeling betrayed by their own biology. Some reached their limit with side effects: relentless nausea, fatigue, or the quiet loss of joy in eating. Others simply couldn’t afford to stay on. A few never saw the promised results at all. But for nearly all of them, the story ended the same way: one step forward, five steps back.
Open in Who Shared Issue with article?

Why does lipoprotein(a) exist?

|
By Larry Kaskel, Robert Laszewski, Carlene MacMillan, L. Alison McInnes
| KevinMD.com
I just read the new Cleveland Clinic Journal of Medicine introduction by its editor-in-chief, and it’s laying out the usual playbook: demonize lipoprotein(a) (Lp(a)), list all the terrible things it does, and hint that salvation is around the corner, pending results of a major pharmaceutical trial, of course. It’s a neat narrative arc. But it’s incomplete. What’s missing is the one question almost no cardiology article seems willing to ask: Why does Lp(a) exist at all?
Open in Who Shared Issue with article?

Why you should get your Lp(a) tested

|
By Monzur Morshed, Kaysan Morshed, Robert Laszewski, Carlene MacMillan
| KevinMD.com
For decades, cholesterol (LDL, HDL, triglycerides) has been the central focus of cardiovascular prevention. But in recent years, another player has emerged: lipoprotein(a), or Lp(a). Many patients have never heard of it, yet research shows it may be one of the most important genetic risk factors for heart disease. What is lipoprotein(a)? Lipoprotein(a) is a particle in the blood similar to LDL cholesterol, but with an added protein called apolipoprotein(a).
Open in Who Shared Issue with article?
See all 207 licensed articles (208 Total)